Smarter transfusions: tailoring blood use after heart surgery
NCT ID NCT07671469
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study compares two ways of deciding when heart surgery patients need a blood transfusion in the ICU. One uses a fixed blood count threshold, while the other also considers each patient's oxygen and lactate levels. The goal is to see if the personalized approach is as safe and reduces blood use. 900 adults at moderate-to-high surgical risk will participate.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Personalized transfusion decision rule (a bedside tool using patient oxygen and lactate levels)
What this could lead to
If it works, this could lead to safer, more efficient blood use after heart surgery, reducing unnecessary transfusions while maintaining patient safety.
What could go wrong
This trial hasn't started yet, and the personalized approach may not prove as safe as the standard one. It's a comparison of existing strategies, not a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University Medical Center
Palo Alto, California, 94305, United States